While the role of IL-18 pathway in systemic JIA is recognized, confirmation of IL-18 pathway involvement may suggest that some children with oligoarticular/polyarticular JIA are candidates for IL-1 targeted therapies. The gene discussed is IL18; the disease is polyarticular juvenile idiopathic arthritis.